Fraquinol
Brand names,
Fraquinol
Analogs
Fraquinol
Brand Names Mixture
Fraquinol
Chemical_Formula
C23H46N6O13
Fraquinol
RX_link
http://www.rxlist.com/cgi/generic3/neomy.htm
Fraquinol
fda sheet
Fraquinol
msds (material safety sheet)
Fraquinol
Synthesis Reference
No information avaliable
Fraquinol
Molecular Weight
614.644 g/mol
Fraquinol
Melting Point
6 mg/mL (as sulfate form)
Fraquinol
H2O Solubility
No information avaliable
Fraquinol
State
Solid
Fraquinol
LogP
-9.895
Fraquinol
Dosage Forms
Powder
Fraquinol
Indication
For the adjunctive treatment of acute hepatic failure, alcoholic cirrhosis of the liver, and suppression of intestinal bacteria.
Fraquinol
Pharmacology
Neomycin is an aminoglycoside antibiotic. Aminoglycosides work by binding to the bacterial 30S ribosomal subunit, causing misreading of t-RNA, leaving the bacterium unable to synthesize proteins vital to its growth. Aminoglycosides are useful primarily in infections involving aerobic, Gram-negative bacteria, such as Pseudomonas, Acinetobacter, and Enterobacter. In addition, some mycobacteria, including the bacteria that cause tuberculosis, are susceptible to aminoglycosides. Infections caused by Gram-positive bacteria can also be treated with aminoglycosides, but other types of antibiotics are more potent and less damaging to the host. In the past the aminoglycosides have been used in conjunction with penicillin-related antibiotics in streptococcal infections for their synergistic effects, particularly in endocarditis. Aminoglycosides are mostly ineffective against anaerobic bacteria, fungi and viruses.
Fraquinol
Absorption
Poorly absorbed from the normal gastrointestinal tract. Although only approximately 3% of neomycin is absorbed through intact intestinal mucosa, significant amounts may be absorbed through ulcerated or denuded mucosa or if inflammation is present.
Fraquinol
side effects and Toxicity
LD50 = 200 mg/kg (rat). Because of low absorption, it is unlikely that acute overdosage would occur with oral neomycin. However, prolonged administration could result in sufficient systemic drug levels to produce neurotoxicity, ototoxicity and/or nephrotoxicity.
Fraquinol
Patient Information
Before administering the drug, patients or members of their families should be informed of possible toxic effects
on the eighth nerve. The possibility of acute toxicity increases in premature infants and neonates.
Fraquinol
Organisms Affected
Enteric bacteria and other eubacteria